Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 383

1.

The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.

Gates GA, Green JD Jr, Tucci DL, Telian SA.

Arch Otolaryngol Head Neck Surg. 2004 Jun;130(6):718-25.

PMID:
15210552
2.

Meniett clinical trial: long-term follow-up.

Gates GA, Verrall A, Green JD Jr, Tucci DL, Telian SA.

Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1311-6.

PMID:
17178941
3.
4.

Positive pressure therapy for Ménière's disease or syndrome.

van Sonsbeek S, Pullens B, van Benthem PP.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD008419. doi: 10.1002/14651858.CD008419.pub2. Review.

PMID:
25756795
5.

Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.

Gürkov R, Filipe Mingas LB, Rader T, Louza J, Olzowy B, Krause E.

J Laryngol Otol. 2012 Apr;126(4):356-62. doi: 10.1017/S0022215112000102. Epub 2012 Feb 27.

PMID:
22365373
7.

Treatment of Meniere's disease with the low-pressure pulse generator (Meniett device).

Gates GA.

Expert Rev Med Devices. 2005 Sep;2(5):533-7. Review.

PMID:
16293064
8.

Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.

Rajan GP, Din S, Atlas MD.

J Laryngol Otol. 2005 May;119(5):391-5.

PMID:
15949105
9.

The effect of the Meniett device in patients with Ménière's disease: long-term results.

Dornhoffer JL, King D.

Otol Neurotol. 2008 Sep;29(6):868-74. doi: 10.1097/MAO.0b013e318182025a.

PMID:
18617868
10.

Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.

Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.

Otolaryngol Head Neck Surg. 2005 Aug;133(2):285-94.

PMID:
16087029
11.

Validation of the Ménière's Disease Patient-Oriented Symptom-Severity Index.

Gates GA, Verrall AM.

Arch Otolaryngol Head Neck Surg. 2005 Oct;131(10):863-7.

PMID:
16230587
12.

Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.

Barbara M, Consagra C, Monini S, Nostro G, Harguindey A, Vestri A, Filipo R.

Acta Otolaryngol. 2001 Dec;121(8):939-44.

PMID:
11813899
13.

Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.

Watanabe Y, Shojaku H, Junicho M, Asai M, Fujisaka M, Takakura H, Tsubota M, Yasumura S.

Acta Otolaryngol. 2011 Nov;131(11):1178-86. doi: 10.3109/00016489.2011.600331. Epub 2011 Aug 15.

PMID:
21838607
14.

Initial symptoms and retrospective evaluation of prognosis in Menière's disease.

Tokumasu K, Fujino A, Naganuma H, Hoshino I, Arai M.

Acta Otolaryngol Suppl. 1996;524:43-9.

PMID:
8790762
15.

[Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].

Faict H, Bouccara D.

Rev Laryngol Otol Rhinol (Bord). 2007;128(1-2):33-6. French.

PMID:
17633662
16.
17.
18.

Transtympanic gentamicin and fibrin tissue adhesive for treatment of unilateral Menière's disease: effects on vestibular function.

Casani A, Nuti D, Franceschini SS, Gaudini E, Dallan I.

Otolaryngol Head Neck Surg. 2005 Dec;133(6):929-35.

PMID:
16360516
19.

Initial UK experience of patient satisfaction with the Meniett® device for Ménière's disease treatment.

Buchanan MA, Rai A, Prinsley PR.

J Laryngol Otol. 2010 Oct;124(10):1067-72. doi: 10.1017/S0022215110001118. Epub 2010 Jun 11.

PMID:
20537216
20.

Supplemental Content

Support Center